Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Immunol ; 20(1-2): 29-31, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18817870

ABSTRACT

Calcineurin inhibitors (CNI) cyclosporine (Csa) and tacrolimus (Tac) are now first intention immunosuppressive drugs in renal transplantation. However, although these treatments are effective for preventing allograft rejection, they are nephrotoxic: they can cause chronic renal dysfunction and degradation of renal graft function [Nankivell BJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec 11;349(24):2326-33]. In view of these undesirable effects, several strategies have been developed to minimize or even avoid their use. These strategies are reviewed and discussed in this paper.


Subject(s)
Calcineurin Inhibitors , Cyclosporine/adverse effects , Immunosuppression Therapy/methods , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Renal Insufficiency/prevention & control , Tacrolimus/adverse effects , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , Basiliximab , Cyclosporine/therapeutic use , Graft Rejection/drug therapy , Graft Survival/drug effects , Graft Survival/immunology , Humans , Immunosuppressive Agents/administration & dosage , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/therapeutic use , Renal Insufficiency/etiology , Tacrolimus/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...